(Q37895398)

24 August 2017

1 reference

title

Adjuvant analgesics in cancer pain: a review (English)

1 reference

24 August 2017

1 reference

Raj Mitra

1

1 reference

24 August 2017

Stephanie Jones

series ordinal

2

1 reference

24 August 2017

publication date

28 June 2011

1 reference

American Journal of Hospice and Palliative Medicine

24 August 2017

published in

1 reference

24 August 2017

volume

29

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

70-79

1 reference

Assessment and treatment of neuropathic cancer pain following WHO guidelines

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Use of antiepileptics and tricyclic antidepressants in cancer patients with neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Bone cancer pain: from model to mechanism to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Antidepressant drugs as adjuvant analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Major depression and demoralization in cancer patients: diagnostic and treatment considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Depression in advanced cancer--a hidden symptom

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Evidence-based data on pain relief with antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Randomized trial of opioids versus tricyclic antidepressants for radiation-induced mucositis pain in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

The pharmacologic treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Doxepin rinse for management of mucositis pain in patients with cancer: one week follow-up of topical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Detection and treatment of akathisia in advanced cancer patients during adjuvant analgesic therapy with tricyclic antidepressants: case reports and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Duloxetine vs. placebo in patients with painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and nerve injured rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Gabapentin inhibits calcium currents in isolated rat brain neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Structure-activity relationships of pregabalin and analogues that target the alpha(2)-delta protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

The analgesic effect of gabapentin as a prophylactic anticonvulsant drug on postcraniotomy pain: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Opioid-induced muscle activity: implications for managing chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Clinical trial of carbazepine (tegretol) in trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Carbamazepine in the treatment of neuralgia. Use of side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Lidocaine test in neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Systemic local anesthetics in pain control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Use of lidocaine patches for neuropathic pain in a comprehensive cancer centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

The use of corticosteroids in the treatment of symptoms associated with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Treatment of painful bone metastases in hormone-refractory prostate cancer with zoledronic acid and samarium-153-ethylenediaminetetramethylphosphonic acid combined

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Adjuvant analgesics in cancer pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Pain killing with calcitonin nasal spray in patients with malignant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

A double-blind controlled trial of salmon calcitonin in pain due to malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Cyclooxygenase (COX)-2 selective inhibitors: aspirin, a dual COX-1/COX-2 inhibitor, to COX-2 selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Nonsteroidal anti-inflammatory drugs as adjuvant analgesics in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic in cancer pain: application in bone metastases and the opioid bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Opioid-sparing effect of diclofenac in cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Baclofen as an adjuvant analgesic for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Diphenhydramine as an analgesic adjuvant in refractory cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Properties of afferent nerve impulses originating from a neuroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111413256

Gabapentin for acute and chronic pain

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD005452

Identifiers

DOI

10.1177/1049909111413256

1 reference

24 August 2017

1 reference